| HGNC Family | CD molecules (CD), Solute carriers (SLC) |
| Name | solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
| Description | Enables L-amino acid transmembrane transporter activity and secondary active transmembrane transporter activity. Involved in carboxylic acid transport; thyroid hormone transport; and xenobiotic transport. Located in several cellular components, including apical plasma membrane; cytosol; and microvillus membrane. Part of amino acid transport complex. Implicated in cholangiocarcinoma; colon cancer; hepatocellular carcinoma; and lung squamous cell carcinoma. Biomarker of esophagitis; gastrointestinal system cancer (multiple); malignant astrocytoma (multiple); and respiratory system cancer (multiple). [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSLC7A5, which encodes the L‐type amino acid transporter 1 (LAT1), is a Na⁺‐independent transporter that mediates the cellular uptake of large neutral amino acids—including essential branched‐chain amino acids and leucine—that are critical for protein synthesis and metabolic signaling. In the brain, LAT1 localizes at the blood–brain barrier where it maintains normal amino acid levels, with loss‐of‐function mutations linked to neurodevelopmental abnormalities and autism spectrum phenotypes. Moreover, LAT1 enables brain drug delivery and facilitates the uptake of PET tracers for glioma imaging, while it also participates in the transport of selective signaling molecules such as S‐nitrosocysteine."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn numerous human cancers—including those of the breast, lung, prostate, gastrointestinal tract, ovary, kidney, and hematopoietic system—as well as in aggressive gliomas, LAT1 is frequently upregulated. Its overexpression, often in partnership with the heavy chain CD98 (encoded by SLC3A2), enhances the uptake of essential amino acids that fuel anabolic processes and activate mTORC1 signaling, thereby promoting cell proliferation, survival, and metastatic progression. Inhibition of LAT1 via small molecule blockers or gene silencing markedly reduces amino acid influx, impairs mTORC1 activity, and sensitizes tumor cells to other treatments, with high LAT1 expression correlating robustly with poor clinical prognosis and aggressive pathological features."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "35"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its prominent role in nutrient uptake and tumor metabolism, LAT1 expression is tightly regulated by a spectrum of intracellular and extracellular cues. Oncogenic transcription factors such as c‐Myc, hypoxia‐inducible factors, and noncoding RNAs (including specific microRNAs and long noncoding RNAs) modulate SLC7A5 expression, thereby integrating metabolic demand with cell‐cycle progression and survival. Structural insights from cryo–electron microscopy studies of the LAT1–CD98 heterodimer have elucidated substrate recognition and transport mechanisms, fueling the development of selective inhibitors. LAT1 also contributes to specialized functions in immune cell activation and placental amino acid transport, underscoring its dual importance in normal physiology and in diverse pathological contexts."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "36", "end_ref": "44"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Sheng Li, A Richard Whorton "}, {"type": "b", "children": [{"type": "t", "text": "Identification of stereoselective transporters for S-nitroso-L-cysteine: role of LAT1 and LAT2 in biological activity of S-nitrosothiols."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M413164200"}], "href": "https://doi.org/10.1074/jbc.M413164200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15769744"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15769744"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "A Habermeier, J Graf, B F Sandhöfer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "System L amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-L-tyrosine (FET)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Amino Acids (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00726-014-1863-3"}], "href": "https://doi.org/10.1007/s00726-014-1863-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25385314"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25385314"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Dora C Tărlungeanu, Elena Deliu, Christoph P Dotter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Impaired Amino Acid Transport at the Blood Brain Barrier Is a Cause of Autism Spectrum Disorder."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cell.2016.11.013"}], "href": "https://doi.org/10.1016/j.cell.2016.11.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27912058"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27912058"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Yongchan Lee, Pattama Wiriyasermkul, Chunhuan Jin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Struct Mol Biol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41594-019-0237-7"}], "href": "https://doi.org/10.1038/s41594-019-0237-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31160781"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31160781"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Hiroshi Nawashiro, Naoki Otani, Nariyoshi Shinomiya, et al. "}, {"type": "b", "children": [{"type": "t", "text": "L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.21866"}], "href": "https://doi.org/10.1002/ijc.21866"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16496379"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16496379"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Kuniaki Nakanishi, Sho Ogata, Hirotaka Matsuo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Virchows Arch (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00428-007-0457-9"}], "href": "https://doi.org/10.1007/s00428-007-0457-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17622555"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17622555"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Hiroshi Nawashiro, Naoki Otani, Youichi Uozumi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High expression of L-type amino acid transporter 1 in infiltrating glioma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Tumor Pathol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10014-005-0188-z"}], "href": "https://doi.org/10.1007/s10014-005-0188-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18095110"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18095110"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "K Kaira, N Oriuchi, H Imai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.bjc.6604235"}], "href": "https://doi.org/10.1038/sj.bjc.6604235"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18253116"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18253116"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Keiichi Kobayashi, Akiko Ohnishi, Jutabha Promsuk, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurosurgery (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1227/01.neu.0000316018.51292.19"}], "href": "https://doi.org/10.1227/01.neu.0000316018.51292.19"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18382329"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18382329"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Kyoichi Kaira, Noboru Oriuchi, Hisao Imai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Res Pract (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.prp.2008.02.003"}], "href": "https://doi.org/10.1016/j.prp.2008.02.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18440724"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18440724"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "David B Shennan, Jean Thomson "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of system L (LAT1/CD98hc) reduces the growth of cultured human breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2008)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18813831"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18813831"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Kyoichi Kaira, Noboru Oriuchi, Hisao Imai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1349-7006.2008.00969.x"}], "href": "https://doi.org/10.1111/j.1349-7006.2008.00969.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19018776"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19018776"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Takeshi Sakata, Golam Ferdous, Tomoko Tsuruta, et al. "}, {"type": "b", "children": [{"type": "t", "text": "L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Int (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1440-1827.2008.02319.x"}], "href": "https://doi.org/10.1111/j.1440-1827.2008.02319.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19121087"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19121087"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Kyoichi Kaira, Noboru Oriuchi, Hisao Imai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lung Cancer (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.lungcan.2008.12.015"}], "href": "https://doi.org/10.1016/j.lungcan.2008.12.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19171406"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19171406"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Brian Z Ring, Robert S Seitz, Rodney A Beck, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel five-antibody immunohistochemical test for subclassification of lung carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mod Pathol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/modpathol.2009.60"}], "href": "https://doi.org/10.1038/modpathol.2009.60"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19430419"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19430419"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Katsuyuki Takeuchi, Sho Ogata, Kuniaki Nakanishi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAT1 expression in non-small-cell lung carcinomas: analyses by semiquantitative reverse transcription-PCR (237 cases) and immunohistochemistry (295 cases)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lung Cancer (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.lungcan.2009.05.020"}], "href": "https://doi.org/10.1016/j.lungcan.2009.05.020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19559497"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19559497"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Kyoichi Kaira, Noboru Oriuchi, Hisao Imai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Surg Oncol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1245/s10434-009-0685-0"}], "href": "https://doi.org/10.1245/s10434-009-0685-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19777189"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19777189"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Shuichi Okubo, Hai-Ning Zhen, Nobuyuki Kawai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Correlation of L-methyl-11C-methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurooncol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11060-010-0117-9"}], "href": "https://doi.org/10.1007/s11060-010-0117-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20091333"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20091333"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Xuetao Fan, Douglas D Ross, Hiroshi Arakawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: a possible target for combination therapy with anti-proliferative aminopeptidase inhibitors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Pharmacol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bcp.2010.05.021"}], "href": "https://doi.org/10.1016/j.bcp.2010.05.021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20510678"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20510678"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Edit Miko, Zoltán Margitai, Zsolt Czimmerer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2011.03.039"}], "href": "https://doi.org/10.1016/j.febslet.2011.03.039"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21439283"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21439283"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Masaaki Ichinoe, Tetuo Mikami, Tsutomu Yoshida, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Int (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1440-1827.2011.02650.x"}], "href": "https://doi.org/10.1111/j.1440-1827.2011.02650.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21501294"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21501294"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Qian Wang, Charles G Bailey, Cynthia Ng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-11-1821"}], "href": "https://doi.org/10.1158/0008-5472.CAN-11-1821"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22007000"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22007000"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Mio Furuya, Jun Horiguchi, Hiroki Nakajima, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1349-7006.2011.02151.x"}], "href": "https://doi.org/10.1111/j.1349-7006.2011.02151.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22077314"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22077314"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Keitaro Hayashi, Promsuk Jutabha, Hitoshi Endou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "c-Myc is crucial for the expression of LAT1 in MIA Paca-2 human pancreatic cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2012.1878"}], "href": "https://doi.org/10.3892/or.2012.1878"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22736142"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22736142"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Nobuyuki Yanagisawa, Masaaki Ichinoe, Tetuo Mikami, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Pathol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/jclinpath-2012-200826"}], "href": "https://doi.org/10.1136/jclinpath-2012-200826"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22813728"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22813728"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Kyoichi Kaira, Yutaka Sunose, Yasuhiro Ohshima, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2407-13-482"}], "href": "https://doi.org/10.1186/1471-2407-13-482"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24131658"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24131658"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Atsushi Isoda, Kyoichi Kaira, Masanori Iwashina, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.12529"}], "href": "https://doi.org/10.1111/cas.12529"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25220100"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25220100"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Ruth Milkereit, Avinash Persaud, Liviu Vanoaica, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms8250"}], "href": "https://doi.org/10.1038/ncomms8250"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25998567"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25998567"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Lara Napolitano, Mariafrancesca Scalise, Michele Galluccio, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAT1 is the transport competent unit of the LAT1/CD98 heterodimeric amino acid transporter."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biochem Cell Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biocel.2015.08.004"}], "href": "https://doi.org/10.1016/j.biocel.2015.08.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26256001"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26256001"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Caroline Papin-Michault, Christelle Bonnetaud, Maxime Dufour, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Study of LAT1 Expression in Brain Metastases: Towards a Better Understanding of the Results of Positron Emission Tomography Using Amino Acid Tracers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0157139"}], "href": "https://doi.org/10.1371/journal.pone.0157139"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27276226"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27276226"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Yann Cormerais, Pierre André Massard, Milica Vucetic, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.RA117.001342"}], "href": "https://doi.org/10.1074/jbc.RA117.001342"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29326164"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29326164"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Bo Ruem Yoon, Yoon-Jeong Oh, Seong Wook Kang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of SLC7A5 in Metabolic Reprogramming of Human Monocyte/Macrophage Immune Responses."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Immunol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fimmu.2018.00053"}], "href": "https://doi.org/10.3389/fimmu.2018.00053"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29422900"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29422900"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Rokaya El Ansari, Madeleine L Craze, Islam Miligy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13058-018-0946-6"}], "href": "https://doi.org/10.1186/s13058-018-0946-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29566741"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29566741"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Pascal Häfliger, Julien Graff, Matthias Rubin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse model."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13046-018-0907-z"}], "href": "https://doi.org/10.1186/s13046-018-0907-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30241549"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30241549"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Renhong Yan, Xin Zhao, Jianlin Lei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41586-019-1011-z"}], "href": "https://doi.org/10.1038/s41586-019-1011-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30867591"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30867591"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Stephanie R Shames, Wanyin Deng, Julian A Guttman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Microbiol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1462-5822.2010.01470.x"}], "href": "https://doi.org/10.1111/j.1462-5822.2010.01470.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20374249"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20374249"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Ainara Elorza, Inés Soro-Arnáiz, Florinda Meléndez-Rodríguez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2012.09.017"}], "href": "https://doi.org/10.1016/j.molcel.2012.09.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23103253"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23103253"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Francesca Gaccioli, Irving L M H Aye, Sara Roos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression and functional characterisation of System L amino acid transporters in the human term placenta."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Reprod Biol Endocrinol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12958-015-0054-8"}], "href": "https://doi.org/10.1186/s12958-015-0054-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26050671"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26050671"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Fredrick J Rosario, Kris Genelyn Dimasuay, Yoshikatsu Kanai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of amino acid transporter trafficking by mTORC1 in primary human trophoblast cells is mediated by the ubiquitin ligase Nedd4-2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Sci (Lond) (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/CS20150554"}], "href": "https://doi.org/10.1042/CS20150554"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26608079"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26608079"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Shushi Nagamori, Pattama Wiriyasermkul, Suguru Okuda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structure-activity relations of leucine derivatives reveal critical moieties for cellular uptake and activation of mTORC1-mediated signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Amino Acids (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00726-015-2158-z"}], "href": "https://doi.org/10.1007/s00726-015-2158-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26724922"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26724922"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Helle Jensen, Marc Potempa, Dagmar Gotthardt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cutting Edge: IL-2-Induced Expression of the Amino Acid Transporters SLC1A5 and CD98 Is a Prerequisite for NKG2D-Mediated Activation of Human NK Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.1700497"}], "href": "https://doi.org/10.4049/jimmunol.1700497"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28784848"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28784848"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Hongliang Li, Shuxian Chen, Jia Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA PVT1-5 promotes cell proliferation by regulating miR-126/SLC7A5 axis in lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2017.12.114"}], "href": "https://doi.org/10.1016/j.bbrc.2017.12.114"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29277611"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29277611"}]}, {"type": "r", "ref": 43, "children": [{"type": "t", "text": "Travis B Salisbury, Subha Arthur "}, {"type": "b", "children": [{"type": "t", "text": "The Regulation and Function of the L-Type Amino Acid Transporter 1 (LAT1) in Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms19082373"}], "href": "https://doi.org/10.3390/ijms19082373"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30103560"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30103560"}]}, {"type": "r", "ref": 44, "children": [{"type": "t", "text": "Yasuhiro Saito, Tomoyoshi Soga "}, {"type": "b", "children": [{"type": "t", "text": "Amino acid transporters as emerging therapeutic targets in cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.15006"}], "href": "https://doi.org/10.1111/cas.15006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34091991"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34091991"}]}]}]}
|
| Synonyms | HLAT1, D16S469E, 4F2LC, E16, MPE16, LAT1 |
| Proteins | LAT1_HUMAN |
| NCBI Gene ID | 8140 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SLC7A5 has 15,099 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 126 datasets.
Click the + buttons to view associations for SLC7A5 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by SLC7A5 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SLC7A5 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of SLC7A5 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SLC7A5 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of SLC7A5 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of SLC7A5 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SLC7A5 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC7A5 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SLC7A5 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SLC7A5 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of SLC7A5 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of SLC7A5 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC7A5 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with SLC7A5 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with SLC7A5 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC7A5 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of SLC7A5 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of SLC7A5 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SLC7A5 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing SLC7A5 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing SLC7A5 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores | cellular components containing SLC7A5 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing SLC7A5 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with SLC7A5 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SLC7A5 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with SLC7A5 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with SLC7A5 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with SLC7A5 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of SLC7A5 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by SLC7A5 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with SLC7A5 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with SLC7A5 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SLC7A5 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with SLC7A5 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with SLC7A5 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for SLC7A5 protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SLC7A5 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC7A5 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of SLC7A5 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing SLC7A5 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with SLC7A5 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC7A5 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with SLC7A5 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing SLC7A5 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of SLC7A5 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SLC7A5 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of SLC7A5 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SLC7A5 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of SLC7A5 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of SLC7A5 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving SLC7A5 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving SLC7A5 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving SLC7A5 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing SLC7A5 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing SLC7A5 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing SLC7A5 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by SLC7A5 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by SLC7A5 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by SLC7A5 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of SLC7A5 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of SLC7A5 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of SLC7A5 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SLC7A5 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of SLC7A5 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with SLC7A5 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with SLC7A5 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC7A5 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for SLC7A5 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC7A5 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of SLC7A5 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of SLC7A5 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SLC7A5 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for SLC7A5 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with SLC7A5 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with SLC7A5 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by SLC7A5 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for SLC7A5 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of SLC7A5 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of SLC7A5 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of SLC7A5 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways 2026 | pathways involving SLC7A5 protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of SLC7A5 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC7A5 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with SLC7A5 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of SLC7A5 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of SLC7A5 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of SLC7A5 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SLC7A5 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain SLC7A5 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by SLC7A5 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting SLC7A5 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of SLC7A5 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of SLC7A5 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by SLC7A5 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of SLC7A5 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of SLC7A5 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing SLC7A5 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for SLC7A5 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SLC7A5 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of SLC7A5 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving SLC7A5 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving SLC7A5 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2014 | pathways involving SLC7A5 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving SLC7A5 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of SLC7A5 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of SLC7A5 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of SLC7A5 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of SLC7A5 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SLC7A5 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SLC7A5 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SLC7A5 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SLC7A5 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with SLC7A5 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of SLC7A5 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of SLC7A5 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of SLC7A5 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of SLC7A5 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of SLC7A5 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of SLC7A5 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of SLC7A5 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SLC7A5 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of SLC7A5 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SLC7A5 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with SLC7A5 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SLC7A5 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving SLC7A5 protein from the WikiPathways Pathways 2024 dataset. | |